Question special
Chief Resident

I think that the science behing this monoclonal antibody against ANGPTL3 is fascinating. Hopefully, this can become an alternative in patients with hypercholesterolemia who are not at their goal LDL despite maximum tolerated doses of statins and other lipid lowering-therapies. For how long would you expect the effect of this drug to last after discontinuation of therapy?